drugset / Trial / NCT00193401
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
Phase 2
Completed
40 enrolled
SCRI Development Innovations, LLC
Institutional Review Board TriStar Nashville Market · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the first-line treatment of elderly and/or poor performance status patients with extensive stage small cell lung cancer. Patients eligible for this trial will be those considered poor candidates for standard combination chemotherapy or other investigational regimens
Timeline
- Start
- 2002-08
- Primary completion
- 2004-06
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topotecan | Small molecule | — | — |